Conrad D. Oja
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
Journal: JAMA
Published: May 24, 2022
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2021
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 02, 2020
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Journal: The Lancet. Oncology
Published: August 05, 2019
Immune system trickery and deception: Allograft-derived neuroendocrine carcinoma post kidney transplantation.
Journal: Urology case reports
Published: September 01, 2018
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
Journal: European urology
Published: July 29, 2018
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
Journal: Journal of the National Cancer Institute
Published: March 06, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026